Meta-analysis of the association of the C677T polymorphism of the methylenetetrahydrofolate reductase gene with hyperuricemia

Annals of Nutrition and Metabolism

Volumn 60, Issue 1, 2012, Pages 44-51

  Wei, Wen ^a,c   Liu, Sheng Yuan ^a,d   Zeng, Fang Fang ^a   Ma, Ling ^a   Li, Ke Shen ^b   Wang, Bin You ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b HARBIN ENGINEERING UNIVERSITY   (China)

^c Taizhou Center for Disease Control and Prevention   (China)

^d Shenzhen Nanshan Center for Chronic Disease Control   (China)

Author keywords

C677T; Hyperuricemia; Meta analysis; MTHFR; Polymorphisms

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYTOSINE; THYMINE; URIC ACID;

ADULT; CASE CONTROL STUDY; CAUCASIAN; CHINESE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; DNA POLYMORPHISM; EMBASE; FEMALE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; HUMAN; HYPERURICEMIA; MALE; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; REVIEW; RISK; SENSITIVITY ANALYSIS;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FAR EAST; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERURICEMIA; IRAN; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84862821307     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000335698     Document Type: Review

References (38)

1. Mutchinick OM, López MA, Luna L, Waxman J, Babinsky VE, Ryvemce Collaborative Group: High prevalence of the thermolabile methylenetetrahydrofolate reductase variant in Mexico: a country with a very high prevalence of neural tube defects. Mol Genet Metab 1999; 68: 461-467. (Pubitemid 30043552)
2. Uehara SK, Rosa G: Association of homocysteinemia with high concentrations of serum insulin and uric acid in Brazilian subjects with metabolic syndrome genotyped for C677T polymorphism in the methylenetetrahydrofolate reductase gene. Nutr Res 2008; 28: 760-766.
3. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Heuvel LP, Rozen R: A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-113.
4. Deloughery TG, Evans A, Sadeghi A, Mc- Williams J, Henner WD, Taylor LM, Press RD: Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine metabolism and late-onset vascular disease. Circulation 1996; 94: 3074-3078. (Pubitemid 26427468)
5. Harmon DL, Woodside JV, Yarnell JW, McMaster D, Young I, McCrum E, Gey K, Whitehead A, Evans AE: The common 'thermolabile'variant of methylenetetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia. Q J Med 1996; 89: 571-577. (Pubitemid 26278868)
6. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R: Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation1996; 93: 7-9. (Pubitemid 26006560)
7. Ma J, Stampfer MJ, Hennekens CH, Frosst P, Selhub J, Horsford J, Malinow MR, Willett WC, Rozen R: Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation 1996; 94:2410-2416. (Pubitemid 26403566)
8. Malinow MR, Nieto FJ, Kruger WD, Duell PB, Hess DL, Gluckman RA, Block PC, Holzgang CR, Anderson PH, Seltzer D, Upson B, Lin QR: The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes. Arterioscler Thromb Vasc Biol 1997; 17:1157-1162. (Pubitemid 27260337)
9. Schwartz SM, Siscovick DS, Malinow MR, Rosendaal FR, Beverly RK, Hess DL, Psaty BM, longstreth WT Jr, Koepsell TD, Raghunathan TE, Reitsma PH: Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene. Circulation 1997; 96: 412-417. (Pubitemid 27329413)
10. Verhoef P, Kok FJ, Kluijtmans LA, Blom HJ, Refsum H, Ueland PM, Kruyssen DACM: The 677CT mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease. Atherosclerosis 1997; 132: 105-113. (Pubitemid 27306745)
11. Wilcken DEL, Wang XL, Wilcken B: Methylenetetrahydrofolate reductase (MTHFR) mutation, homocyst(e)ine, and coronary artery disease. Circulation 1997; 96: 2738-2740. (Pubitemid 27451376)
12. Kang SS, Wong PWK, Cook HY, Norusis M, Messer JV: Protein-bound homocysteine: a possible risk factor for coronary artery disease. J Clin Invest 1986; 77: 1482-1486. (Pubitemid 16047091)
13. Motti C, Gnasso A, Bernardini S, Massoud R, Pastore A, Rampa P, Federici G, Cortese C: Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine and other risk factors for vascular disease. Atherosclerosis 1998; 139: 377-383. (Pubitemid 28361823)
14. Beckler MA, Roessler BJ: Hyperuricemia and gout; in Scriver CR, Beaudet AL, Sly WS, Valle D (eds): The Metabolic Basis of Inherited Disease. New York, McGraw-Hill, 1995, pp 1655-1677.
15. Zuo M, Nishio H, Lee MJ, Maejima K, Mimura S, Sumino K: The C677T mutation in the methylene tetrahydrofolate reductase gene increases serum uric acid in elderly men. J Hum Genet 2000; 45: 257-262. (Pubitemid 30482989)
16. Hong YS, Lee MJ, Kim KH, Lee SH, Lee YH, Kim BG, Jeong B, Yoon HR, Nishio H, Kim JY: The C677 mutation in methylene tetrahydrofolate reductase gene: correlation with uric acid and cardiovascular risk factors in elderly Korean men. J Korean Med Sci 2004; 19: 209-213. (Pubitemid 38591793)
17. Yao H, Ding LL, Wang XM, Xu FL: Polymorphisms of methylenetetrahydrofolate reductase C677T and hyperuricemia in males. Ai Bian Ji Bian Tu Bian 2007; 19: 50-52.
18. Golbahar J, Aminzadeh MA, Al-Shboul QM, Kassab S, Rezaian GR: Association of methylenetetrahydrofolate reductase (C677T) polymorphism with hyperuricemia. Nutr Metab Cardiovasc Dis 2006; 17: 462-467.
19. Shi HY, Dong YH, Nan HT, Qian WW, Qian RL: The association of methylenetetrahydrofolate reductase (MTHFR) gene C677T mutation with hyperuricemia. Chin J Diabetes 2006; 14: 178-181.
20. Lwin H, Yokoyama T, Yoshiike N, Saito K, Yamamoto A, Date C, Tanaka H: Polymorphism of methylenetetrahydrofolate reductase gene (C677T MTHFR) is not a confounding factor of the relationship between serum uric acid level and the prevalence of hypertension in Japanese men. Circ J 2006; 70: 83-87. (Pubitemid 43021239)
21. Yamamoto T: Definition and classification of hyperuricemia. Nippon Rinsho 2008; 66:636-640.
22. Motulsky AG: Nutritional ecogenetics: homocysteine- related arteriosclerotic vascular disease, neural tube defects, and folic acid. Am J Hum Genet 1996; 58: 17-20.
23. Cochran WG: The combination of estimates from different experiments. Biometrics 1954;10: 101-129.
24. Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560. (Pubitemid 37088507)
25. Copas J, Shi JQ: Meta-analysis, funnel plots and sensitivity analysis. Biostatistics 2000; 1:247-262. (Pubitemid 33213534)
26. Sterne JA, Egger M, Smith GD: Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis. BMJ 2001; 323: 101-105. (Pubitemid 32681979)
27. Mao R, Fan Y, Jin Y, Bai J, Fu S: Methylenetetrahydrofolate reductase gene polymorphisms and lung cancer: a meta-analysis. J Hum Genet 2008; 53: 340-348.
28. Sterne JA, Harbord RM: Funnel plots in meta- analysis. Stata J 2004; 2: 127-141.
29. Silverman EK, Palmer LJ: Case-control association studies for the genetics of complex respiratory diseases. Am J Respir Cell Mol Biol 2000; 22: 672-675.
30. Xu J, Turner A, Little J, Bleecker ER, Meyers DA: Positive results in association studies are associated with departure from Hardy-Weinberg equilibrium: hint for genotyping error? Hum Genet 2002; 111: 573-574. (Pubitemid 36075091)
31. Whitfield JB, Martin NG: Plasma lipids in twins. Environmental and genetic influences. Atherosclerosis 1983; 48: 265-277. (Pubitemid 13048864)
32. Emmerson BT, Nagel SL, Duffy DL, Martin NG: Genetic control of the renal clearance of urate: a study of twins. Ann Rheum Dis 1992; 51: 375-377.
33. Tuomilehto J, Zimmet P, Wolf E, Taylor R, Ram P, King H: Plasma uric acid level and its association with diabetes mellitus and some biologic parameters in a biracial population of Fiji. Am J Epidemiol 1988; 127: 321-336. (Pubitemid 18056385)
34. Seegmiller JE: The clinical significance of hyperuricemia. Med Ann Dist Columbia 1967; 36: 215-218.
35. Sperling O, Wyngaarden JB, Starmer CF: The kinetics of intramolecular distribution of 15N in uric acid after administration of (15N) glycine. A reappraisal of the significance of preferential labeling of N-(3+9) of uric acid in primary gout. J Clin Invest 1973; 52: 2468-2485.
36. Akaoka I, Fujimori S, Kamatani N, Takeuchi F, Yano E, Nishida Y, Hashimoto A, Horiuchi Y: A gouty family with increased phosphoribosylpyrophosphate synthetase activity: case reports, familial studies, and kinetic studies of the abnormal enzyme. J Rheumatol 1981; 8: 563-574. (Pubitemid 12244877)
37. Fang J, Alderman MH: Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 2000; 283: 2404-2410. (Pubitemid 30257539)
38. Schork MA: Publication bias and meta analysis. J Hypertens 2003; 21: 243-245. (Pubitemid 36269687)